{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-073099","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.097654+00:00","generated_at":"2026-05-21T03:53:27.136939+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"STAAR Surgical announces $30M buyback and China NMPA approval for EVO+ TICL","bullets":["Authorized $30M share repurchase program, expected to run over six months from cash on hand.","Company had $222.8M cash and equivalents, no debt as of March 28, 2025; ~49.5M shares outstanding.","China's NMPA approved EVO+ Toric ICL for myopia correction (-0.5D to -18D, astigmatism ≤6D).","EVO+ spheric ICL application remains pending with NMPA; Switzerland manufacturing validations ongoing for China supply."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-073099","json":"https://secwatch.observer/filing/0000950170-25-073099.json","markdown":"https://secwatch.observer/filing/0000950170-25-073099.md","text":"https://secwatch.observer/filing/0000950170-25-073099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000095017025073099/0000950170-25-073099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000095017025073099/staa-20250516.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T03:53:27.136939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}